Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $(0.39) by 166.16 percent. This is a 160.47 percent increase over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $30.917 million which beat the analyst consensus estimate of $878.600 thousand by 3.42K percent. This is a 12.12K percent increase over sales of $253.000 thousand the same period last year.